Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03175471 · ClinicalTrials.gov registry record
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
A clinical trial of Primary Sclerosing Cholangitis and Autoimmune Hepatitis, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 115
- Enrollment target
- 1
- Study location
NCT03175471 is a study of Primary Sclerosing Cholangitis and Autoimmune Hepatitis that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 115 participants, below the 548-participant average among 23 other Primary Sclerosing Cholangitis trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03175471, a study of Primary Sclerosing Cholangitis and Autoimmune Hepatitis, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
Autoimmune liver diseases (AILD), which include Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH) are a common etiological factors for chronic liver disease among adolescents. In all these conditions, autoimmune lymphocyte responses are thought to orchestrate inflammatory injury against hepatocytes (primarily in AIH) or cholangiocytes (in PSC). In this proposal we aim to evaluate the Magnetic Resonance Imaging (MRI) modalities; MR cholangiopancreatography (MRCP) and MR elastography (MREL), as non-invasive biomarkers to assess two primary pathophysiological processes of AILD: bile duct damage and liver fibrosis. In this cross-sectional study MRI based findings of bile duct injury and liver fibrosis will be correlated with both liver histology and circulating biomarkers of these disease processes.
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Childrens Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2017-01-17 |
| Est. Completion | 2027-01-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03175471
The ClinicalTrials.gov registry entry for NCT03175471 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 548-participant average among 23 other Primary Sclerosing Cholangitis trials with a reported enrollment target (79% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Primary Sclerosing Cholangitis appearing as the primary indexed condition, and to 0 interventions.
NCT03175471 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03175471 about?
NCT03175471 is a clinical study titled "MRI Based Biomarkers in Pediatric Autoimmune Liver Disease". Autoimmune liver diseases (AILD), which include Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH) are a common etiological factors for chronic liver disease among adolescents. In all these conditions, autoimmune lymphocyte responses are thought to orchestrate inflammatory injury ag...
What is the current status of trial NCT03175471?
This trial is currently recruiting. The enrollment target is 115 participants. The study started on 2017-01-17. Estimated completion is 2027-01-30.
What conditions does trial NCT03175471 study?
This clinical trial studies the following conditions: Primary Sclerosing Cholangitis, Autoimmune Hepatitis, Autoimmune Liver Disease.
Who is sponsoring clinical trial NCT03175471?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03175471 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Sclerosing Cholangitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
RECRUITING · Phase 2
-
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
RECRUITING
-
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
RECRUITING
-
Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
RECRUITING · Early Phase 1
-
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
RECRUITING
-
Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.